The global tissue diagnostics market was valued at US$ 32.0 Bn in 2021 and is set to expand at a healthy CAGR of 12.8% during 2022-2032, with a market valuation of US$ 120.2 Bn by 2032.
“Upsurge in the cancer incidences and rising presence of various medical and biotechnology firms across the world is expected to uplift the tissue diagnostics market growth.”
A group of human cells that play an important role in executing several biological functions that are crucial for other healthy functions in the human body are referred to as tissues. Tissue diagnostics is an important field of diagnostics research. The tissue sample explains several aspects of the different biological situations.
Tissue diagnostics have played a major role in the field of cancer analysis and diagnostics. It helps researchers and scientists to identify the presence of cancer by examining the tissue samples. It is also gaining popularity in the different diagnostic fields. In the leading pharmaceutical companies, the study of different chronic diseases’ origin and treatment is carried out. Due to this tissue diagnostics are gaining more popularity in other diagnostics areas.
Data Points
Key Statistics
Tissue Diagnostics Market Size in 2021
US$ 32.0 Bn
Tissue Diagnostics Market Size in 2032
US$ 120.2 Bn
Tissue Diagnostics Market CAGR (2022-2032)
12.8%
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
What are the Factors Responsible for the Growth of the Tissue Diagnostics Market?
The increasing incidence and prevalence of various types of cancer, such as lung cancer and breast cancer, are expected to boost the tissue diagnostics market over the forecast period.
Additionally, innovations in devices to detect the type of cancerous tissue, a spike in technical enhancements that support the improved imaging of hazardous cells, and a rise in the precision of the outcome could help the tissue diagnostics market in achieving growth throughout the forecast period. Furthermore, increased government and private organizations’ initiatives to create awareness to identify and prevent early cancer are predicted to propel market expansion in the projected years.
Moreover, improved infrastructure of diagnostics laboratories in developed countries is expected to boost the market in the near future. Owing to the growing disposable income of the populace, the spending capability of people on health has increased. Thus, people concerned about their health are highly spending money on diagnostic treatments, even for minor symptoms. This will boost market demand.
Which Region Shows Strong Growth Potential in the Tissue Diagnostics Market?
On the basis of geographies, the global tissue diagnostics market is divided into seven major regions- North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.
The tissue diagnostic market in North America is expected to maintain its hold during the forecast period followed by Europe and the Asia Pacific. Owing to the factors such as high spending on research and development activities in the biotechnology and medical equipment organizations as well as the extensive use of novel technologies, the North American region is attributed to boosting the market growth in the upcoming years.
On the other hand, Asia Pacific is anticipated to show rapid growth in the projected period. The upsurge in the medical tourism business in the nations like China and India is expected to increase the demand for diagnosis and treatment in this region. Furthermore, due to the increase in cancer cases and other disorders will further propel the market growth for tissue diagnostics.
Find your sweet spots for generating winning opportunities in this market.
Who are the Key Market Players in the Tissue Diagnostics Market?
Some of the key players operating in the infection control market are Agilent Technologies, Danaher Corporation, F. Hoffmann-La Roche Ltd, BIOMÉRIEUX, Abbott Laboratories, Merck KGaA, General Electric Company (GE Healthcare), BioGenex, Cell Signaling Technology, Inc., and Koninklijke Philips N.V.
Scope of Report
Report Attribute
Details
Growth Rate
CAGR of 12.8% from 2022-2032
Base Year for Estimation
2021
Historical Data
2012-2021
Forecast Period
2022-2032
Qualitative Units
US$ Billion for Value
Report Coverage
Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered
Product
Disease
Application
End User
Region
Region Covered
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa
Key Countries Profiled
U.S
Canada
Brazil
Mexico
Germany
U.K
France
Spain
Italy
China
Japan
South Korea
Malaysia
Singapore
Australia
New Zealand
GCC
South Africa
Israel
Key Companies Profiled
Agilent Technologies
Danaher Corporation
F. Hoffmann-La Roche Ltd
BIOMÉRIEUX
Abbott Laboratories
Merck KGaA
General Electric Company (GE Healthcare)
BioGenex
Cell Signaling Technology, Inc.
Koninklijke Philips N.V.
Customization
Available Upon Request
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Key Segments Covered in the Tissue Diagnostics Market Report
By Product:
Instruments
Microscope
Non-contact Handheld IR Thermometer
Haemocytometer
NMR Tube
Others
Consumables
Reagent Kits
Others
By Disease:
Lung Cancer
Lymphoma
Pancreatic
Cancer
Breast Cancer
Others
By Application:
In Situ Hybridization
Hematoxylin and Eosin (H&E)
Immunohistochemistry (IHC)
By End User:
Diagnostic Laboratories
Hospitals
Contract Research Organizations
Research Organizations
Biotechnology Companies
By Region:
North America
Latin America
Europe
East Asia
South Asia & Pacific
The Middle East and Africa (MEA)
Frequently Asked Questions
The global tissue diagnostics market is anticipated to register a CAGR of 12.8% during the forecast period.
The tissue diagnostics market is projected to be about US$ 120.2 Bn by the end of year 2032.
- Request for Table of Contents -
Complete the form below and we'll get back to you shortly
